Mounrjaro hits shelves in India: How Eli Lilly’s anti-diabetes drug compares with Ozempic — price, side effects and more
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...
The Financial Express4h
As Eli Lilly’s popular weight loss drug enters India, doctors warn of potential misuse
Chemically known as tirzepatide, Mounjaro is currently sold in the UK and Europe under the same brand name for both diabetes ...
Eli Lilly Launches Weight Loss Drug In India: What You Should Know About Mounjaro
By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and ...
Eli Lilly Shares Are Up Today: What's Going On?
Eli Lilly & Co. (NYSE: LLY) shares are trading higher Thursday after the company launched its weight-loss drug Mounjaro in ...
Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India. Prices here
Eli Lilly's much-anticipated drug for diabetes and obesity, that competes with Ozempic globally, is now in India. Here's what ...
Eli Lilly launches its blockbuster weight loss drug Mounjaro in India
The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...
Eli Lilly's weight loss drug Mounjaro launched in India; check prices, how it works
Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...
Eli Lilly’s weight loss drug launches in India: Here are 4 things to know about Mounjaro
The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...
Obesity and diabetes management drug launched in India by American pharma company Eli Lilly
Eli Lilly launches diabetes and obesity drug Mounjaro in India, offering innovative treatment for metabolic health management ...